Abstract
ObjectiveLonger-term effects of prolonged selective interleukin-1β blockade with canakinumab were evaluated in the largest cohort of cryopyrin-associated periodic syndrome (CAPS) patients studied to date.MethodsAdult and paediatric CAPS patients (n=166, including...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have